Vince & Associates, an Altasciences Company, to Evaluate Marijuana Compound in Clinical Trial

OVERLAND PARK, Kan.–(BUSINESS WIRE)–Vince Associates will conduct an inpatient clinical trial on the
psychological effects of an active ingredient in marijuana — cannabidiol
— in support of a federal collaboration seeking to better understand the
abuse potential of the substance.

Vince Associates was awarded a research subcontract valued at $2.8
million from Leidos Biomedical Research Inc., prime contractor for the
government-sponsored Frederick National Laboratory for Cancer Research
in Frederick, Md., which is administering the effort. Funding for the
project comes from the National Institute on Drug Abuse (NIDA), part of

... read more at: http://www.businesswire.com/news/home/20171011005621/en/Vince-Associates-Altasciences-Company-Evaluate-Marijuana-Compound

by